Skip to Main Content
Sign in to myUHN Patient Portal

About the Hyperbaric Medicine Unit

Wheelchair icon

Location

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​Toronto General Hospital | map iconMaps & Directions
Peter Munk Building – Ground Floor, Room 107​​

Hours & Contact

Monday – F​riday
7:15 am – 4:30 pm

Phone: 416 340 3598
Fax: 416 340 4481
Contact: Gabriela Argumendo
Email: hyperbaricmedicineunit@uhn.ca

What We Do

Hyperbaric oxygen therapy uses 100 percent oxygen, administered at an increased atmospheric pressure. It increases the amount of oxygen that is carried by the blood, to areas of the body with compromised blood supply. Other effects of hyperbaric oxygen therapy include growth of new vessels, optimization of  white blood cell function, and restoration of tissue metabolic balance.

Using a large, 8-person chamber, as well as three single person chambers, our unit offers:

  • Elective hyperbaric therapy
  • Urgent care hyperbaric therapy
  • Wound assessments
  • Transcutaneous oximetry

The Hyperbaric Medicine Unit follows treatment guidelines that have been established by the Undersea and Hyperbaric Medical Society (UHMS).​

 Health Information

Resources from the Patient & Family Education Program PDF Icon

* These material(s) are also available in other languages.

​Visit our Health Information section and find dedicated resources to help you understand your condition. Find the information​ you'r​e looking for.​​​​​​​​​

 Conditions treated

  • Acute thermal burn injury
  • Air or gas embolism
  • Arterial insufficiencies (central retinal artery occlusion; Enhancement of healing in selected problem wounds)
  • Carbon monoxide poisoning
  • Carbon monoxide poisoning complicated by cyanide poisoning
  • Clostridial myositis and myonecrosis (gas gangrene)
  • Compromised grafts and flaps
  • Crush injury, compartment syndrome and other acute traumatic ischemias
  • Decompression sickness
  • Delayed radiation injury (soft tissue and bony necrosis)
  • Idiopathic Sudden Sensorineural Hearing Loss (Approved on October 8, 2011, by the UHMS Board of Directors)
  • Intracranial abscess
  • Necrotizing soft tissue infections
  • Osteomyelitis (refractory)
  • Severe anemia​​​​​​​​​​​​